Frankfurt - Delayed Quote EUR

Viking Therapeutics, Inc. (1VT.F)

Compare
32.38
+1.14
+(3.65%)
At close: January 29 at 8:10:46 AM GMT+1
All numbers in thousands
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
368,490.00
168,529.00
210,662.00
256,502.00
Total Liabilities Net Minority Interest
20,071.00
23,207.00
8,778.00
12,158.00
Total Equity Gross Minority Interest
348,419.00
145,322.00
201,884.00
244,344.00
Total Capitalization
348,419.00
145,322.00
201,884.00
244,344.00
Common Stock Equity
348,419.00
145,322.00
201,884.00
244,344.00
Capital Lease Obligations
1,260.00
1,564.00
29.00
359.00
Net Tangible Assets
348,419.00
145,322.00
201,884.00
244,344.00
Working Capital
348,090.00
145,093.00
201,750.00
243,975.00
Invested Capital
348,419.00
145,322.00
201,884.00
244,344.00
Tangible Book Value
348,419.00
145,322.00
201,884.00
244,344.00
Total Debt
1,260.00
1,564.00
29.00
359.00
Share Issued
102,307.02
80,450.51
78,248.40
73,215.94
Ordinary Shares Number
100,113.77
78,257.26
78,248.40
73,215.94
Treasury Shares Number
2,193.25
2,193.25
--
--
12/31/2020 - 5/11/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers